University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 16 of 23
Developmental Outcomes
NCT02264808
The Peds Obesity Study
NCT02353637
Emotion Study -- A Neurofeedback Approach
NCT02194907
Pharmacological Effects of Crushing Prasugrel in STEMI Patients
NCT02212028
Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients
NCT02133872
Papaya Study ID:20140628
NCT02051634
Limb Cooling in Essential Tremor
NCT02067702
Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer
NCT02148159
Inspired Helium for Ischemic Protection During Knee Replacement Surgery
NCT02012361
Arterial Stiffness in Type I Diabetes Mellitus
NCT02218268
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
NCT02183519
Phase I, Dose Escalation Study of Decitabine
NCT02264873
Observational Study of Biomarker During Liver Surgery
NCT02102971
Strain Imaging in Breast Cancer Patients Receiving Trastuzumab
NCT02080390
Cognitive Behavioral Treatment for Improving Sleep in Overweight and Obese Youth
NCT02232217
KAATSU Training to Enhance Physical Function of Older Adults With Osteoarthritis
NCT02132715
Respiratory Load Magnitude Estimation in PD
NCT02202057
Lidocaine For Treatment of Post-operative Pain From Donor Sites Following Burn Injury.
NCT02229578
Effect of Gardening on Brain Activity
NCT02225847
Optimizing Resilience In Orofacial Pain and Nociception
NCT02164630
Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy
NCT02199366
The WISE (Weightloss Intervention Surgical Effects) Brain Study
NCT02137070
Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care
NCT02188667
The Role of Gut Microbiota in Hypertension
NCT02188381
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle
NCT02168114
Neuronal and Glial Biomarkers in Stroke
NCT02409043
The Strong Brain Study
NCT02320864
Metabolic Costs of Daily Activities in Older Adults
NCT02129855
The Childhood Health and Asthma Management Program
NCT02303561
The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23
NCT02097589
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
NCT02137096
An Emergency Department-To-Home Intervention to Improve Quality of Life and Reduce Hospital Use
NCT02079987
Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant Depression
NCT02141776
Neuroimaging of Dystonia
NCT02046447
Effect of Ankle Splinting on Vascular Function in Aging
NCT02144896
The Effect of Low Furanocoumarin Grapefruit Hybrid Juice Consumption on Midazolam Pharmacokinetics
NCT02117869
Battery-preserving Stimulation Patterns for Deep Brain Stimulation
NCT02569021
Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia
NCT02116166
The Microbiology of Caries Resistance
NCT02130206
Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy
NCT02083419
The Effects of Modified Ultrafiltration on Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery
NCT02051595
Emotional Communication Disorders in Cerebellar Disease
NCT02106819
In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
NCT02081443
Tourette Syndrome Deep Brain Stimulation
NCT02056873
Acidophilus Pearls Fecal Recovery Study
NCT02001610
A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:
NCT02065479
Muscle Injury Prevention & Rehabilitation in Military Personnel
NCT02077413
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
NCT02016170
Association Between Haptoglobin Genotype and Brain Swelling
NCT02054117
Study of Glycogen Storage Disease Expression in Carriers
NCT02057731
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.